Psychological Aspects of Menopause

Psychological Symptoms - Menopause Mood Maze

• Common Manifestations:
  • Mood swings: Irritability, sadness, tearfulness.
  • Anxiety: Generalized, panic attacks.
  • Depressive mood: New onset or worsening.
  • Cognitive changes ("Brain Fog"): ↓ concentration, memory lapses.
  • Sleep disturbances: Insomnia, fragmented sleep (due to VMS).
  • ↓ Libido: Linked to mood & local symptoms.
• Key Influencers:
  • Estrogen ↓: Affects serotonin, norepinephrine, dopamine.
  • Vasomotor Symptoms (VMS): Disrupt sleep, worsen mood.
  • Psychosocial factors: Midlife stressors, aging, empty nest.
  • Past mood disorders (PMS, PPD): ↑ vulnerability.

⭐ Perimenopause is often the period of highest vulnerability for mood symptoms, even before complete cessation of menses.

​

Etiology & Risk Factors - Hormone Headaches & Hurdles

Psychological symptoms primarily stem from fluctuating and declining ovarian hormones, directly impacting brain neurochemistry and function.

• Key Hormonal Drivers:
  • Estrogen ↓ & Fluctuations: Central to mood lability, cognitive changes, and sleep disruption.

    ⭐ Fluctuations in estrogen, rather than absolute low levels, are strongly implicated in perimenopausal mood lability.

  • Progesterone ↓: Its decline contributes significantly to anxiety and sleep disturbances.
  • Testosterone ↓: Reduced levels may adversely impact libido, overall energy, and mood.
• Risk Factors:
  • Biological: History of mood disorders (e.g., PMDD, PPD), abrupt surgical menopause, severe vasomotor symptoms (VMS).
  • Psychosocial: Chronic high stress, inadequate social support, negative cultural perception of menopause.
  • Lifestyle: Smoking, sedentary habits, persistent poor sleep patterns.

Assessment & Management - Mind Mend Methods

• Assessment:

  • Standardized Scales: PHQ-9 (depression), GAD-7 (anxiety), Menopause Rating Scale (MRS).
  • Clinical Evaluation: History of mood (depression, irritability), anxiety, sleep disturbances (insomnia), cognitive concerns ("brain fog").
  • Differential Diagnosis: Rule out organic causes (e.g., thyroid dysfunction, anemia, Vit B12 deficiency).

• Management Strategy:

*   **Non-Pharmacological:**
    *   Lifestyle: Regular exercise, balanced diet (phytoestrogens), sleep hygiene, stress management (yoga, mindfulness).
    *   Psychotherapy: Cognitive Behavioral Therapy (CBT) first-line for mood/anxiety; Interpersonal therapy (IPT).
*   **Pharmacological:**
    *   Hormone Replacement Therapy (HRT): Effective for VMS-associated mood/anxiety. Use lowest effective dose.
    *   Antidepressants: SSRIs (e.g., **Escitalopram**, **Sertraline**) for moderate-severe depression/anxiety. SNRIs (e.g., **Venlafaxine**, **Desvenlafaxine**) also treat VMS.
    *   Anxiolytics: Short-term Benzodiazepines (cautious use).
    *   Non-hormonal VMS relief: **Gabapentin**, **Pregabalin**.
> ⭐ For women with menopause-associated depression, Hormone Replacement Therapy (HRT) can be considered first-line if they also have vasomotor symptoms; SSRIs are preferred for moderate-severe depression or if HRT is contraindicated.

High‑Yield Points - ⚡ Biggest Takeaways

• Vasomotor symptoms (hot flashes) strongly correlate with mood lability, anxiety, and sleep issues.
• Increased risk of depression (new/recurrent) in perimenopause; prior history is a key risk.
• Subjective cognitive complaints ("brain fog") are common; objective deficits less consistent.
• Decreased libido and sexual dysfunction significantly impact psychological well-being.
• Psychosocial stressors and negative attitudes towards menopause can worsen symptoms.
• Hormone Therapy (HT) can improve mood/anxiety, especially if linked to vasomotor symptoms.